SEC Company Response from Addex Therapeutics (ADXN) — Dec 3, 2025
Addex Therapeutics Ltd.
Date: Dec. 3, 2025 · CIK: 0001574232 · Accession: 0001104659-25-118120
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291644
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance Attention: Mr. Chris Edwards File No. 333-291644 Acceleration Request Requested Date: December 5, 2025 Requested Time: 4:15 p.m., Eastern Time
Dear Mr. Edwards:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Addex Therapeutics Ltd (the " Company ") hereby requests that the effective date of the above-referenced registration statement (the " Registration Statement ") be accelerated to December 5, 2025, at 4:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Kristopher Brown at (212) 813-8821.
If you have any questions regarding this request, please contact Kristopher Brown of Goodwin Procter LLP at (212) 813-8821.
Sincerely,
ADDEX THERAPEUTICS LTD
Show Raw Text
CORRESP 1 filename1.htm December 3, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Mr. Chris Edwards Re: Addex Therapeutics Ltd Acceleration Request for Registration Statement on Form F-3 File No. 333-291644 Acceleration Request Requested Date: December 5, 2025 Requested Time: 4:15 p.m., Eastern Time Dear Mr. Edwards: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Addex Therapeutics Ltd (the " Company ") hereby requests that the effective date of the above-referenced registration statement (the " Registration Statement ") be accelerated to December 5, 2025, at 4:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Kristopher Brown at (212) 813-8821. If you have any questions regarding this request, please contact Kristopher Brown of Goodwin Procter LLP at (212) 813-8821. Sincerely, ADDEX THERAPEUTICS LTD /s/ Tim Dyer Tim Dyer Chief Executive Officer cc: Kristopher Brown, Esq., Goodwin Procter LLP Justin Platt, Esq., Goodwin Procter LLP